|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 207/14 | |
| C07D 403/12 | |||
| C07D 403/14 | |||
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| A61K 31/40 | |||
| A61P 3/06 |
| (11) | Patento numeris | 2229356 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08857355.5 |
| Europos patento paraiškos padavimo data | 2008-12-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-10-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/066537 |
| Data | 2008-12-01 |
| (87) | Numeris | WO 2009/071509 |
| Data | 2009-06-11 |
| (30) | Numeris | Data | Šalis |
| 991891 P | 2007-12-03 | US |
| (72) |
MOGI, Muneto, US
KAWANAMI, Toshio, US
YAMADA, Ken, US
YASOSHIMA, Kayo, US
IMASE, Hidetomo, US
MIYAKE, Takahiro, JP
OHMORI, Osamu, JP
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS |
| 1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS |